insights_auto
Outlook: 57.9% bullish·0.0% bearish
Go to analysischevron_right
CSL:ASX
CSL Ltd
A$180.72
arrow_upward
+1.36%(+2.42) 1D
Sep 22, 4:11:24 PM GMT+10 · AUD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSL...
Open
A$180.00
High
A$180.95
Low
A$179.25
Mkt. cap
86.72B
Avg. vol.
1.55M
Volume
856.74K
Dividend
1.57%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2025
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.53
Shares outstanding
479.88M
No. of employees
29K
Open
A$180.00
High
A$180.95
Low
A$179.25
Mkt. cap
86.72B
Avg. vol.
1.55M
Volume
856.74K
Dividend
1.57%
Quarterly dividend
A$0.71
Ex-dividend date
Sep 9, 2025
52-wk high
A$222.47
52-wk low
A$90.00
EPS
-A$7.53
Shares outstanding
479.88M
No. of employees
29K
News stories
From web sources and news partners
The Motley Fool Australia
·
2 hours ago
Up 98%: Are CSL shares now a buy, hold or sell?
Kalkine Media
·
19 hours ago
Could CSL (ASX:CSL) Stay a Bluechip Stocks Cornerstone?
Kalkine
·
22 hours ago
CSL Limited Buys Back 43,219 Shares on 21 September in On-Market Programme
Kalkine Media
·
1 day ago
What Does CSL Limited (ASX:CSL) Capital Return Program Mean for Bluechip Stocks?
Profile
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
About CSL Ltd
CEOPaul McKenzie
Employees29K
Founded1916
HeadquartersMelbourne, Victoria, Australia
SectorBiotechnology
Websitecsl.com